Philips Medical Systems North America of Shelton, CT, has received Food and Drug Administration clearance for a new MRI upgrade package that includes high-end features such as cardiac scanning protocols and neuro imaging techniques. The package is
Philips Medical Systems North America of Shelton, CT, has received Food and Drug Administration clearance for a new MRI upgrade package that includes high-end features such as cardiac scanning protocols and neuro imaging techniques. The package is available on the companys Gyroscan NT line of magnets.
In the neuro imaging realm, the new package includes an option supporting diffusion, perfusion, and functional brain imaging, which can help in the early detection of stroke. On the cardiac side, the package enables a Gyroscan NT site to conduct cardiac MRI without purchasing additional hardware. One feature of the package, MotionTrak, enables users to control motion artifacts through gating and slice tracking. Other features of the new package include advancements in MR angiography, MR spectroscopy, and coil technology.
MRI Study at ARRS Raises Questions About Disparities in Detection of MASLD
May 3rd 2025New research revealed that Hispanic Americans with evidence of hepatic steatosis on MRI but no formal diagnosis of MASLD had over a fourfold higher risk of developing hepatocellular carcinoma in comparison to those who had a formal diagnosis of MASLD.